Bavarian Nordic A/S

OVERVALUEDBVNRY · OTC · Healthcare
BVNRY·OTC·Healthcare
OVERVALUED
Bavarian Nordic A/S
12.5%downside
MARKET PRICE
$9.65
FAIR PRICE
$8.44
MARGIN
$1.21
UNDERVALUEDFAIROVERVALUED
P/E RATIO
6.0x
DIV. YIELD
N/A
ROE
20.3%
MARKET CAP
$14B
FPI
fairpriceindex.com

FAIR PRICE VALUATION

12.5%downside

Updated daily

Model: DCF 50% · Relative 30% · Consensus 20%

MARKET PRICE

$9.65

FAIR PRICE

$8.44

MARGIN

$1.21

UNDERVALUEDFAIROVERVALUED

P/E Ratio

6.0x

What is P/E? →

Div. Yield

N/A

ROE

20.3%

Strong

Market Cap

$14B

Large-cap

NOW AVAILABLE

Get notified when BVNRY's fair price changes

Push notifications when BVNRY's valuation shifts. Available on iOS and Android.

Download on the App StoreGet it on Google Play

FPI RATING

8.8/ 10

Strong profitability and consistent growth trajectory, but volatile earnings pattern.

Analytical data, not an investment recommendation. Updated daily.

How we calculate this ↗

MARGIN OF SAFETY

A 20% margin of safety below fair value — the conservative entry level for risk-aware investors.

$6.75CONSERVATIVE ENTRY
$8.44FAIR PRICE
$9.65MARKET PRICE

SAFETY MARGIN

20%

Below fair value

ENTRY LEVEL

$6.75

Fair price × 0.80

DISTANCE

30.0%

Price to entry level

At the current price of $9.65, BVNRY trades 30.0% above the conservative entry level of $6.75. This entry level represents a 20% margin of safety below the calculated fair price of $8.44 — a buffer that accounts for estimation uncertainty in the valuation model.

Margin of safety is a risk management concept, not an investment recommendation. The 20% threshold follows Benjamin Graham's value investing framework. Fair price and entry levels are model-based estimates updated daily. Learn more about Margin of Safety ↗

VALUATION HISTORY

Loading chart data...

P/E RATIO HISTORY

Loading chart data...

METHODOLOGY

How we calculate BVNRY's fair price

Bavarian Nordic A/S's fair price of $8.44 is derived from a blended model that combines DCF analysis (50%), relative valuation against Healthcare peers using metrics like P/E and EV/EBITDA (30%), and analyst consensus (20%). At the current market price of $9.65, BVNRY trades 12.5% above its calculated fair value.

DCF MODEL · 50%

Discounted free cash flow analysis based on projected cash flows, discounted at a rate reflecting BVNRY's risk profile.

RELATIVE · 30%

Comparing BVNRY's valuation multiples against Healthcare peers to determine if the stock is over or undervalued relative to its industry.

ANALYST · 20%

Aggregated analyst price targets for BVNRY, weighted by recency and analyst accuracy.

TRY IT YOURSELF

Want to test your own assumptions? Use our free calculators to estimate BVNRY's fair value with your own inputs.

LEARN MORE

Bulios

POWERED BY BULIOS

Get full analysis, financials, and AI insights for BVNRY.

Explore on Bulios

FAQ

What is the fair price of BVNRY?+

Based on our blended model combining DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%), the fair price for Bavarian Nordic A/S is $8.44. At the current market price of $9.65, BVNRY trades 12.5% above its calculated fair value.

Is BVNRY overvalued or undervalued?+

Bavarian Nordic A/S is currently overvalued based on our valuation model. The stock trades at $9.65, which is 12.5% above the fair price of $8.44. The P/E ratio of 6.0x is a key metric in the valuation.

What is the margin of safety for BVNRY?+

With a 20% margin of safety applied to the fair price of $8.44, the conservative entry level for BVNRY is $6.75. At the current market price of $9.65, the stock trades 30.0% above this entry level. Margin of safety is a risk management concept from Benjamin Graham's value investing framework, not an investment recommendation.

How often is BVNRY's fair price updated?+

We update fair price calculations for BVNRY daily after market close. The current fair price of $8.44 incorporates the latest market data and sector multiples.

What factors affect BVNRY's fair price calculation?+

BVNRY's fair price of $8.44 is derived from DCF analysis (50% weight), relative valuation against Healthcare peers (30% weight), and analyst consensus (20% weight). Key metrics include P/E of 6.0x, ROE of 20.3%.

Is BVNRY a good buy right now?+

At $9.65, BVNRY trades 12.5% above our fair value estimate of $8.44. The stock is currently overvalued. ROE stands at 20.3% (strong). Fair Price Index provides valuation data — always do your own research before investing.

Does BVNRY pay dividends?+

BVNRY does not currently pay a dividend.

RELATED STOCKS

Fair Price Index is for informational purposes only and does not constitute investment advice. Fair value calculations are model-based estimates and may not reflect actual market conditions. Always conduct your own research before making investment decisions.